| Term 
 
        | what are the three CLASSES of SKELETAL MUSCLE RELAXANTS? |  | Definition 
 
        | COMPETITIVE BLOCKS-block neuromuscular jxn 
 DEPOLARIZING BLOCKS-mimic Ach-->fasciculations-->paralysis
 
 ANTISPASMOTICS-centrally and muscle acting
 |  | 
        |  | 
        
        | Term 
 
        | what affect do VOLATILE ANESTHETICS have on MUSCLE RELAXANTS? |  | Definition 
 
        | volatile anesthetics ENHANCE the effects of muscle relaxants--> less needed for same result |  | 
        |  | 
        
        | Term 
 
        | LONG ACTING competitive muscle relaxants? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | INTERMEDIATE ACTING competitive muscle relaxants? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SHORT ACTING competitive muscle relaxants? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SHORT acting depolarizing blockers? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are SKELETAL MUSCLE RELAXANTS used for? |  | Definition 
 
        | -intubation -stop peristalsis
 -electroshock therapy
 |  | 
        |  | 
        
        | Term 
 
        | what substance can be released with SMR? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SMR are contraindicated in what conditions? |  | Definition 
 
        | -myesthenia gravis -asthma
 -plasma cholinesterase deficiencies
 |  | 
        |  | 
        
        | Term 
 
        | what are the SPASMOLYTICS? |  | Definition 
 
        | -baclofen -tizanidine
 -dantroline
 -botulinum toxin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -upper motor neuron lesions -MS
 -spinal cord injuries
 -cerebral palsy
 -post stroke
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SPASMOLYTIC-->centrally acting -GABA b receptor agonist
 -used in MS
 **problem: high doses=DROWSINESS
 INTRATHECAL PUMP is implanted for slow release= LESS DROWSINESS**
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SPASMOLYTIC -alpha2 receptor agonist
 -decreases SYMPATHETIC TONE
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SPASMOLYTIC-->acts at neuromuscular junction ***antidote for MALIGNANT HYPERTHERMIA*** prevents Ca++ release
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SPASMOLYTIC-->acts at neuromuscular junction -blocks Ach release from presynaptic terminal
 -used in distal upper limbs/not lower
 ***BLACK BOX WARNING AGAINST USE IN CEREBRAL PALSY***
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DEPOLARIZING agent -short acting--> first FASCICULATIONS then PARALYSIS
 -can cause HYPERKALEMIA
 ***can cause MALIGNANT HYPERTENSION***--> use DANTROLINE
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | LONG ACTING competitive/non depolarizing agent |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | LONG ACTING competitive/non depolarizing agent -Nn blocking
 -increase HISTAMINE RELEASE
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | INTERMEDIATE ACTING competitive/non depolarizing agent |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | INTERMEDIATE ACTING competitive/non depolarizing agent -NO HISTAMINE release, NO GANGLIONIC block
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SHORT ACTING competitive/non depolarizing agent -increases HISTAMINE release
 ***cleared by plasma CHOLINESTERASES***
 |  | 
        |  |